BioLife Solutions, Inc. (BLFS): Price and Financial Metrics


BioLife Solutions, Inc. (BLFS): $43.10

-0.13 (-0.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BLFS POWR Grades


  • BLFS scores best on the Growth dimension, with a Growth rank ahead of 68.48% of US stocks.
  • BLFS's strongest trending metric is Stability; it's been moving up over the last 31 weeks.
  • BLFS's current lowest rank is in the Stability metric (where it is better than 21.56% of US stocks).

BLFS Stock Summary

  • Price to trailing twelve month operating cash flow for BLFS is currently 224.49, higher than 98.2% of US stocks with positive operating cash flow.
  • With a price/sales ratio of 33.09, Biolife Solutions Inc has a higher such ratio than 92.65% of stocks in our set.
  • With a year-over-year growth in debt of 865.8%, Biolife Solutions Inc's debt growth rate surpasses 98.34% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Biolife Solutions Inc are CSTL, SWTX, BLI, VUZI, and EPAY.
  • BLFS's SEC filings can be seen here. And to visit Biolife Solutions Inc's official web site, go to www.biolifesolutions.com.

BLFS Price Target

For more insight on analysts targets of BLFS, see our BLFS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $56.43 Average Broker Recommendation 1.56 (Moderate Buy)

BLFS Stock Price Chart Interactive Chart >

Price chart for BLFS

BLFS Price/Volume Stats

Current price $43.10 52-week high $47.97
Prev. close $43.23 52-week low $15.05
Day low $42.20 Volume 50,387
Day high $43.41 Avg. volume 293,698
50-day MA $34.06 Dividend yield N/A
200-day MA $35.06 Market Cap 1.74B

BioLife Solutions, Inc. (BLFS) Company Bio


BioLife Solutions, Inc. develops, manufactures, and markets patented tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, and delayed-onset cell damage and death. The company was founded in 1987 and is based in Bothell, Washington.


BLFS Latest News Stream


Event/Time News Detail
Loading, please wait...

BLFS Latest Social Stream


Loading social stream, please wait...

View Full BLFS Social Stream

Latest BLFS News From Around the Web

Below are the latest news stories about Biolife Solutions Inc that investors may wish to consider to help them evaluate BLFS as an investment opportunity.

BioLife Solutions Adopts New Brand Identity

BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced the launch of its new corporate brand identity, redesigned logo, and website. The new brand identity was created to better reflect BioLife's expanded portfolio of bioproduction tools and services.

Yahoo | June 15, 2021

This Is The Reason Why We Think BioLife Solutions, Inc.'s (NASDAQ:BLFS) CEO Deserves A Bump Up To Their Compensation

The impressive results at BioLife Solutions, Inc. ( NASDAQ:BLFS ) recently will be great news for shareholders. At the...

Yahoo | June 12, 2021

Company News for May 17, 2021

Companies In The News Are: ACB, NEWR, BLFS, GLOB

Yahoo | May 17, 2021

Analysts Have Made A Financial Statement On BioLife Solutions, Inc.'s (NASDAQ:BLFS) First-Quarter Report

BioLife Solutions, Inc. ( NASDAQ:BLFS ) investors will be delighted, with the company turning in some strong numbers...

Yahoo | May 16, 2021

Biolife Solutions Inc (BLFS) Q1 2021 Earnings Call Transcript

BLFS earnings call for the period ending March 31, 2021.

Yahoo | May 14, 2021

Read More 'BLFS' Stories Here

BLFS Price Returns

1-mo 32.49%
3-mo 10.63%
6-mo -1.42%
1-year 171.24%
3-year 241.79%
5-year 2,560.49%
YTD 8.05%
2020 146.54%
2019 34.50%
2018 100.50%
2017 272.67%
2016 -25.81%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9152 seconds.